Although somewhat upregulated by individual treatments with EGF or ST, Zeb2/SIP1 was repressed in the combined treatment at all timepoints (fig 4) suggesting this Zeb family member is less likely to be involved in Snail1-driven breast cancer EMT. The gene discussed is ZEB2; the disease is breast carcinoma.